FRP-4 activators belong to a distinct chemical class characterized by their ability to modulate the activity of the FRP-4 receptor, a protein receptor found predominantly in cellular membranes. These activators are designed to interact specifically with the FRP-4 receptor, eliciting a cascade of intracellular events that regulate cellular responses. Structurally, FRP-4 activators exhibit a diverse range of chemical compositions, but they share a commonality in their capacity to bind selectively to the FRP-4 receptor, triggering a conformational change that initiates downstream signaling pathways. The specificity of FRP-4 activators for this receptor distinguishes them from other compounds and underscores their potential utility in studying cellular processes governed by the FRP-4 signaling pathway.
Research on FRP-4 activators has primarily focused on elucidating the molecular mechanisms underlying their interaction with the FRP-4 receptor. The modulation of cellular functions by these activators may involve the activation or inhibition of key intracellular pathways, influencing processes such as gene expression, cell proliferation, and differentiation. Understanding the structural features of FRP-4 activators and their precise binding sites on the FRP-4 receptor is crucial for advancing our knowledge of cellular signaling and may have implications for the development of novel research tools in cell biology. The exploration of FRP-4 activators contributes to the broader scientific understanding of cellular communication and opens avenues for further investigations into the functional roles of the FRP-4 signaling pathway in various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Modulates GSK-3β, a key regulator of the Wnt pathway, potentially leading to the activation of SFRP4. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
Inhibits GSK-3β, influencing the Wnt pathway and possibly leading to the activation of SFRP4. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt secretion, a pathway where SFRP4 operates, thereby potentially influencing SFRP4 activity indirectly. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Acts as an N-glycosylation inhibitor, potentially affecting the glycosylation of SFRP4 and its regulatory function. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
An alpha-mannosidase inhibitor that may influence glycosylation processes, potentially impacting SFRP4 activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Hormone with potential to influence cellular signaling, possibly impacting pathways involving SFRP4 activation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor, affecting epigenetic changes that could indirectly influence SFRP4 activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially influencing epigenetic changes associated with SFRP4 activation. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
An antioxidant with potential effects on reactive oxygen species, which may indirectly impact pathways involving SFRP4. | ||||||